Exagen Diagnostics Awarded $400,000 in Grants Under the QTDP Program
Exagen Diagnostics Inc has been awarded $400,000 in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program.
Read MorePosted by Clinical Lab Products | Dec 22, 2010 | Miscellaneous |
Exagen Diagnostics Inc has been awarded $400,000 in funding under the IRS Qualifying Therapeutic Discovery Project (QTDP) program.
Read MorePosted by Clinical Lab Products | Dec 17, 2010 | Cancer, Miscellaneous |
As the former president and CEO of both a diagnostic product company and a laboratory testing company, Davis is an acknowledged diagnostic industry expert.
Read MorePosted by Clinical Lab Products | Dec 8, 2010 | Miscellaneous |
Mandatory genetic screening of newborns for rare diseases is creating unexpected upheaval for families whose infants test positive for risk factors but show no immediate signs of the diseases, a new UCLA study warns.
Read MorePosted by Clinical Lab Products | Dec 6, 2010 | Cancer, Miscellaneous |
This new division will create genetic diagnostic tests that determine an individual’s risk of developing a disease.
Read MorePosted by Clinical Lab Products | Dec 3, 2010 | Cancer, Clinical Chemistry, Clinical Chemistry Analyzers, Clinical Chemistry Test Kits |
Multiplex Lyme, Syphilis, and ToRCH IgG The AtheNA Multi-Lyte® menu offered by Alere Inc, Waltham, Mass, includes three new infectious disease assays. Borrelia VlsE-1/ pepC10 is used as a first-tier test to detect qualitative levels of B. bu
Read More